Feasibility Study for Collaborate2Lose

University of Wisconsin (UW)

Status: Completed

Conditions: Obesity

Treatments: Behavioral: Partner support

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT05646771

Protocol Version 1/24/23 (Other Identifier)

SMPH/SURGERY/WISOR (Other Identifier)

2021-0629

Details and patient eligibility

About

In this feasibility study, dyads comprising a Veteran with obesity and a cohabiting adult support person will participate in group-based weight management counseling. Counseling will be delivered using an approved virtual technology platform. The curriculum is based on the VA national MOVE! weight management curriculum and involves additional content focusing on couples' communication skills.

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (Veteran):

1. Aged 18 years or older
2. BMI ≥ 30 kg/m2
3. Had at least one visit with their primary care provider at the Madison VA within the past year (in-person or telehealth)
4. Weight ≤ 420lbs due to limit of the study scales
5. Cohabitating and daily contact for at least the past 6 months with an adult who can provide support (e.g. spouse/domestic partner, sibling, friend, family member) during the study period
6. Desire to lose weight
7. Ability to speak English
8. Agrees to attend visits per protocol
9. Score of at least 4 out of 6 on a validated cognitive screener
10. Access to hardware and internet connection to enable participation with approved virtual platform
11. Individual email address
12. Able to stand on a scale without assistance

Exclusion Criteria (Veteran):

1. Medication other than metformin, incretin mimetics and incretin enhancers for type 2 diabetes due to increased risk for hypoglycemia
2. Active dementia, psychiatric illness, or substance abuse
3. History of bariatric surgery
4. Diuretic medication doses higher than hydrochlorothiazide 25 mg daily, furosemide 40 mg daily, Torsemide 20 mg daily, Bumetanide 1 mg daily or any use of Metolazone). Use of potassium-sparing diuretics is acceptable.
5. Chronic kidney disease at stage 4 or higher
6. Participation in MOVE! in the past 3 months
7. Currently enrolled in a research or clinical program focusing on lifestyle change
8. Pregnancy or planning to become pregnant in the next 18 months, or breastfeeding
9. Psychiatric illness not well-controlled by medication or therapy
10. Score ≥ 8 on alcohol abuse screener
11. Use of any drugs not prescribed, excluding cannabis
12. Weight loss ≥ 10lb in the month prior to screening
13. Living in a facility such as a nursing home, skilled nursing facility, or assisted living facility
14. Is unable to control what food is prepared and/or served in household
15. Problems with hearing that prevent attendance to a virtual class and talking on the telephone
16. Currently enrolled in a research or clinical program focusing on lifestyle change
17. History of bariatric surgery (reconfirm) or planning to have bariatric surgery in the next 18 months
18. Current use of weight loss medications
19. Worsening heart failure requiring medication dose change in the past 6 months
20. Hospitalization for heart problems in the past 6 months
21. Current treatment or treatment in the past 6 months for cancer (besides non-melanoma skin cancers)
22. Dizziness or lightheadedness at rest or associated with physical activity
23. Chest pain in the past 6 months

Inclusion Criteria (support person):

1. Aged 18 years or older
2. Willing to participate
3. Score of at least 4 out of 6 on a validated cognitive screener
4. Ability to speak English

Exclusion Criteria (support person):

1. Underweight (BMI < 18.5 kg/m2)
2. Active dementia, uncontrolled psychiatric illness, or substance abuse
3. Living in a facility such as a nursing home, skilled nursing facility, or assisted living facility
4. Problems with hearing that prevent attendance to a virtual class and talking on the telephone
5. Any severe health issue that would impair the partner's ability to provide support

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Partner-Supported

Experimental group

Description:

Dyads comprised of one Veteran and a cohabitating support person will participate in a behavioral weight management intervention.

Treatment:

Behavioral: Partner support